Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Aspirin DL-lysine [JAN]
RN: 62952-06-1
UNII: 2JJ274J145
InChIKey: JJBCTCGUOQYZHK-UHFFFAOYSA-N

Classification Code

  • Drug / Therapeutic Agent

Molecular Formulas

  • C9-H8-O4.C6-H14-N2-O2
  • C9-H8-O4.x-C6-H14-N2-O2

Molecular Weight

  • 326.347
 
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Regulatory Agencies (Superlist Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Aspirin DL-lysine [JAN]
  • Lysine acetylsalicylate

Synonyms

  • Acetyl salicylate lysine
  • Acetylsalicylic acid lysine salt
  • ASL
  • Aspegic
  • Aspirin DL-lysine
  • Aspisol
  • DL-Lysine acetylsalicylate
  • DL-Lysine acetylsalicylic acid salt
  • EINECS 263-769-3
  • UNII-2JJ274J145
  • Venopirin

Systematic Names

  • D,L-lysine, 2-(acetyloxy)benzoate
  • DL-Lysine mono(o-acetoxybenzoate)
  • DL-Lysine-acetylsalicylate
  • L-Lysine, 2-(acetyloxy)benzoate, mixt. with glycine
  • Lysine, 2-(acetyloxy)benzoate (1:1)
  • Lysine, mono(2-(acetyloxy)benzoate)
  • Lysine, monosalicylate acetate (ester), DL-

Registry Numbers

CAS Registry Number

  • 62952-06-1

FDA UNII

  • 2JJ274J145

Other Registry Numbers

  • 107032-89-3
  • 123445-32-9
  • 145607-63-2
  • 34220-70-7
  • 50641-50-4
  • 51024-94-3
  • 77337-52-1
  • 92520-58-6
  • 97598-63-5
  • 98806-35-0

System Generated Number

  • 0062952061

Molecular Formulas

Molecular Formulas

  • C9-H8-O4.C6-H14-N2-O2
  • C9-H8-O4.x-C6-H14-N2-O2

Molecular Formula Fragments

  • C6-H14-N2-O2
  • C9-H8-O4
  • COMPONENT

Structure Descriptors

InChI

1S/C9H8O4.C6H14N2O2/c1-6(10)13-8-5-3-2-4-7(8)9(11)12;7-4-2-1-3-5(8)6(9)10/h2-5H,1H3,(H,11,12);5H,1-4,7-8H2,(H,9,10)

InChIKey

JJBCTCGUOQYZHK-UHFFFAOYSA-N

Smiles

c1(c(cccc1)OC(C)=O)C(=O)[O-].C(CCC[NH3+])[C@@H](C(O)=O)N

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intravenous 143mg/kg (143mg/kg)   Russian Pharmacology and Toxicology Vol. 51, Pg. 183, 1988.
mouse LD50 oral 3270mg/kg (3270mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 6, Pg. 1275, 1978.
mouse LD50 subcutaneous 1gm/kg (1000mg/kg)   Pharmaceutical Chemistry Journal Vol. 21, Pg. 341, 1987.
rat LD50 intramuscular 1660mg/kg (1660mg/kg)   Russian Pharmacology and Toxicology Vol. 51, Pg. 183, 1988.
rat LD50 intravenous 1525mg/kg (1525mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 6, Pg. 1275, 1978.
rat LD50 oral 4350mg/kg (4350mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 6, Pg. 1275, 1978.
rat LD50 subcutaneous 1860mg/kg (1860mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 6, Pg. 1275, 1978.

Physical Properties

Physical Property Value Units Temp (deg C) Source
Melting Point 155 deg C   EXP
log P (octanol-water) -4.720 (none)   EST
Atmospheric OH Rate Constant 5.50E-11 cm3/molecule-sec 25 EST

Physical property data is provided to ChemIDplus by SRC, Inc.